Thank you and well done.
I don't feel qualified to challenge the analysis, just two comments:
1. Peer analysis might be a reasonable guide to inform our own expectations and the potential, but there will be other non-objective factors that will come into play for the suitor. Company strategy, competition, current financials, external market factors, alignment/opportunities with other IP, etc. What I am trying to say is that the amount that the suitor will be prepared to pay will be driven by whatever THEY think its worth TO THEM.
2. The pressure is on @RaceOncology. You don't want to disappoint Mason with a sub $27b outcome!
- Forums
- ASX - By Stock
- Speculative M&A Transaction Analysis
Thank you and well done.I don't feel qualified to challenge the...
-
-
- There are more pages in this discussion • 846 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.58 |
Change
0.040(2.60%) |
Mkt cap ! $269.2M |
Open | High | Low | Value | Volume |
$1.60 | $1.60 | $1.55 | $150.3K | 96.09K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 81 | $1.58 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.59 | 2472 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 81 | 1.580 |
2 | 5635 | 1.575 |
2 | 16186 | 1.570 |
2 | 10056 | 1.560 |
3 | 34981 | 1.550 |
Price($) | Vol. | No. |
---|---|---|
1.590 | 2472 | 1 |
1.600 | 12088 | 2 |
1.620 | 2000 | 1 |
1.650 | 7731 | 1 |
1.685 | 5000 | 1 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online